Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel

Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.

Publication ,  Journal Article
Palacio Rojas, M; Prieto, C; Bermúdez, V; Garicano, C; Núñez Nava, T; Martínez, MS; Salazar, J; Rojas, E; Pérez, A; Marca Vicuña, P; Cano, C ...
Published in: F1000Research
January 2017

The direct link between lipid metabolism alterations and the increase of cardiovascular risk are well documented. Dyslipidemias, including isolated high LDL-c or mixed dyslipidemia, such as those seen in diabetes (hypertriglyceridemia, high LDL-c or low HDL-c), correlate with a significant risk of cardiovascular and cerebrovascular disease worldwide.  This review analyzes the current knowledge concerning the genetic basis of lipid metabolism alterations, emphasizing lipoprotein lipase gene mutations and the HindIII polymorphism, which are associated with decreased levels of triglycerides and LDL-c, as well as higher levels of HDL-c. These patterns would be associated with decreased global morbidity and mortality, providing protection against cardiovascular and cerebrovascular diseases.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

F1000Research

DOI

EISSN

2046-1402

ISSN

2046-1402

Publication Date

January 2017

Volume

6

Start / End Page

2073

Related Subject Headings

  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Palacio Rojas, M., Prieto, C., Bermúdez, V., Garicano, C., Núñez Nava, T., Martínez, M. S., … Rojas, J. (2017). Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism. F1000Research, 6, 2073. https://doi.org/10.12688/f1000research.12938.2
Palacio Rojas, Marcos, Carem Prieto, Valmore Bermúdez, Carlos Garicano, Trina Núñez Nava, María Sofía Martínez, Juan Salazar, et al. “Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.F1000Research 6 (January 2017): 2073. https://doi.org/10.12688/f1000research.12938.2.
Palacio Rojas M, Prieto C, Bermúdez V, Garicano C, Núñez Nava T, Martínez MS, et al. Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism. F1000Research. 2017 Jan;6:2073.
Palacio Rojas, Marcos, et al. “Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.F1000Research, vol. 6, Jan. 2017, p. 2073. Epmc, doi:10.12688/f1000research.12938.2.
Palacio Rojas M, Prieto C, Bermúdez V, Garicano C, Núñez Nava T, Martínez MS, Salazar J, Rojas E, Pérez A, Marca Vicuña P, González Martínez N, Maldonado Parra S, Hoedebecke K, D’Addosio R, Cano C, Rojas J. Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism. F1000Research. 2017 Jan;6:2073.

Published In

F1000Research

DOI

EISSN

2046-1402

ISSN

2046-1402

Publication Date

January 2017

Volume

6

Start / End Page

2073

Related Subject Headings

  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0601 Biochemistry and Cell Biology